Small molecule inhibitors of the fosfomycin resistance enzyme FosM from Mycobacterium abscessus

Skye Chiasson, Tatum Smith, Landon Bello, Nishad Thamban Chandrika, Keith D. Green, Sylvie Garneau-Tsodikova, Matthew K. Thompson

Producción científica: Articlerevisión exhaustiva

Resumen

Fosfomycin is a safe broad-spectrum antibiotic that has not achieved widespread use because of the emergence of fosfomycin-modifying enzymes. Inhibition of fosfomycin-modifying enzymes could be used to help combat pathogens like Mycobacterium abscessus. Our previous work identified several inhibitors for the enzyme FosB from Staphylococcus aureus. We have tested those same compounds for inhibition of FosM, the fosfomycin-modifying enzyme from M. abscessus. The work described here will be used as the basis for more detailed studies into the inhibition of FosM.

Idioma originalEnglish
Número de artículo130444
PublicaciónBiochimica et Biophysica Acta - General Subjects
Volumen1867
N.º10
DOI
EstadoPublished - oct 2023

Nota bibliográfica

Publisher Copyright:
© 2023 Elsevier B.V.

Financiación

This work was supported by The University of Alabama startup funds, the Cystic Fibrosis Foundation Grant # THOMPS2010 , and National Institutes of Health grant # 1R15GM148956 . This work was supported by The University of Alabama startup funds, the Cystic Fibrosis Foundation Grant #THOMPS2010, and National Institutes of Health grant #1R15GM148956.M. K. T. would like to acknowledge the generosity of the Richard N. Armstrong family and Vanderbilt University Department of Biochemistry for initial laboratory equipment along with plasmids and reagents specific to this project. S. C. would like to acknowledge the Department of Education GAANN Grant #P200A150329. M. K. T. would like to acknowledge the generosity of the Richard N. Armstrong family and Vanderbilt University Department of Biochemistry for initial laboratory equipment along with plasmids and reagents specific to this project. S. C. would like to acknowledge the Department of Education GAANN Grant # P200A150329 .

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)1R15GM148956
U.S. Department of Education, OSERSP200A150329
Cystic Fibrosis Foundation HeadquartersTHOMPS2010
Department of Chemistry, Vanderbilt University
University of Alabama

    ASJC Scopus subject areas

    • Biophysics
    • Biochemistry
    • Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Small molecule inhibitors of the fosfomycin resistance enzyme FosM from Mycobacterium abscessus'. En conjunto forman una huella única.

    Citar esto